Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore
Completed
- Conditions
- Intussusception
- Interventions
- Other: Screening sheets
- Registration Number
- NCT01177839
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
This prospective study aims to estimate the incidence of intussusception among children \< 2 years old through hospital-based surveillance in Singapore.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 178
Inclusion Criteria
- A male or female infant aged < 24months at the time of diagnosis of intussusception.
- Subject is diagnosed with definite, probable, possible, suspected intussusception during the period of at least one year beginning at study start.
- Written informed consent obtained from the parent or guardian of the subject.
Exclusion Criteria
- A male or female infant ≥ 24 months of age at the time of intussusception diagnosis.
- The subject has had a radiographically or surgically confirmed case of intussusception prior to the current episode.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Intussusception cohort Screening sheets Subjects with Intussusception
- Primary Outcome Measures
Name Time Method Occurrence of definite, probable and possible IS cases in children < 5 yrs of age Average timeframe: one year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
GSK Investigational Site
🇸🇬Singapore, Singapore